Biologics are preparations, such as a drug, a vaccine or an antitoxin, that are synthesized from living organisms or their products and used as a diagnostic, preventive or therapeutic agent.

For the development and proving of biological pharmaceuticals, CPI provides assets and resources to support innovations in the manufacture of biologics, with access state-of-the-art facilities and technical expertise. Capability and support for Biologics spans across: rapid process development tools and techniques for current and next generation biologics; formulation, fill and finish focused on the biologics market; specialist process analytical technologies; supply chain alignment with the future needs of healthcare providers; and workforce training and development. HVM Catapult Biologics expertise and equipment can help commercialise ideas and take them to market faster and with reduced risk.